Amundi Asset Management US Inc. Has $169.90 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Amundi Asset Management US Inc. reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 33.4% in the 1st quarter, Holdings Channel reports. The firm owned 2,155,330 shares of the company’s stock after selling 1,082,767 shares during the period. Amundi Asset Management US Inc.’s holdings in Colgate-Palmolive were worth $169,903,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CL. Goodwin Investment Advisory acquired a new position in shares of Colgate-Palmolive during the first quarter worth $26,000. Grant Street Asset Management Inc. bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $28,000. TRU Independence Asset Management 2 LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $29,000. Encompass Wealth Advisors LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $29,000. Finally, Better Money Decisions LLC bought a new stake in shares of Colgate-Palmolive in the first quarter worth $31,000. Institutional investors own 75.85% of the company’s stock.

In other news, CTO Patricia Verduin sold 46,566 shares of the stock in a transaction that occurred on Wednesday, May 5th. The shares were sold at an average price of $80.89, for a total transaction of $3,766,723.74. Following the completion of the transaction, the chief technology officer now directly owns 100,680 shares of the company’s stock, valued at approximately $8,144,005.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Noel R. Wallace sold 25,279 shares of the stock in a transaction that occurred on Wednesday, May 5th. The shares were sold at an average price of $81.03, for a total transaction of $2,048,357.37. Following the transaction, the chief executive officer now directly owns 257,057 shares of the company’s stock, valued at $20,829,328.71. The disclosure for this sale can be found here. In the last quarter, insiders sold 91,040 shares of company stock valued at $7,384,255. Company insiders own 0.32% of the company’s stock.

Several analysts recently weighed in on the stock. Credit Suisse Group raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $80.00 to $95.00 in a research note on Wednesday, June 9th. Zacks Investment Research raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $85.00 price target on the stock in a research report on Monday, May 3rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company a “hold” rating in a research report on Monday, May 3rd. Evercore ISI reaffirmed a “buy” rating and set a $95.00 price target on shares of Colgate-Palmolive in a research report on Sunday, June 20th. Finally, UBS Group began coverage on shares of Colgate-Palmolive in a research report on Wednesday, June 23rd. They set a “buy” rating and a $95.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $85.62.

CL opened at $82.18 on Thursday. The company has a quick ratio of 0.64, a current ratio of 1.01 and a debt-to-equity ratio of 11.42. Colgate-Palmolive has a fifty-two week low of $72.61 and a fifty-two week high of $86.41. The firm has a market cap of $69.52 billion, a price-to-earnings ratio of 26.51, a PEG ratio of 4.20 and a beta of 0.61. The stock has a 50-day simple moving average of $82.85.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Thursday, April 29th. The company reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.01. The firm had revenue of $4.34 billion during the quarter, compared to analyst estimates of $4.28 billion. Colgate-Palmolive had a net margin of 15.92% and a return on equity of 298.80%. The company’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter last year, the business posted $0.75 EPS. Sell-side analysts predict that Colgate-Palmolive will post 3.28 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 16th. Shareholders of record on Wednesday, July 21st will be paid a $0.45 dividend. The ex-dividend date of this dividend is Tuesday, July 20th. This represents a $1.80 annualized dividend and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Featured Story: FinTech

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.